News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Industry
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014
Vortex To Accelerate Anti-Infective Research At The Institute For Molecular Bioscience At The University of Queensland, Australia 8/20/2014
Antisense Therapeutics Limited (ANP.AX) Release: Strategy Update - ATL1103 & ATL1102 8/20/2014
Creative BioMart Launches Novel Service For Protein Labeling 8/20/2014
American Institute of Biological Sciences Release: New Initiative Will Improve Access To Biological Collections, Data 8/20/2014
Swimming Supports Science: Scienion AG Contributes To The "Rheines Wasser" Project With Microarray-Based Multiparameter Testing Of Waterborne Pathogens All Along The River Rhine 8/20/2014
Massachusetts Biotechnology Council, Inc. Release: MA Seed-Stage Funding At Critical Juncture 8/20/2014
Agilent Technologies Inc. (A) And Shimadzu Corporation Enable Control Of Each Other’s GC Instruments In Respective Chromatographic Data Systems 8/20/2014
Contract Research Organization Pharma Start Improves Audit Readiness With Paperless eTMF Solution From Veeva Systems, Inc. 8/20/2014
Orthofix, Inc. (OFIX) Updates Filing Status 8/20/2014
Ohio Clinical Trials Collaborative Release: Novel Human Tissue Samples Available For Research and Development 8/20/2014
Orexo AB (ORXOF) Enhances Commercial Focus And Operating Efficiencies 8/20/2014
inGenious Targeting Laboratory, Inc. Scores Multiple Contracts For Use Of Innovative TruHumanization™ Technology 8/20/2014
Coquí RadioPharmaceuticals's $250 Million Facility To Bring 164-High-Paying Jobs To Alachua 8/20/2014
FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences) 8/20/2014
Fibrocell Science, Inc. To Move Stock Listing To NASDAQ 8/19/2014
Nutra Pharma Corp. (NPHC) Provides Nyloxin® Marketing Updates 8/19/2014
Axxess Pharma, Inc. Reports Increased Global Sales Fueled By Aggressive Social Media Marketing, Additional Distributor Relationships And Celebrity Athlete Sponsorships 8/19/2014
Globavir Biosciences, Inc. Seeking Approval and Launch of Novel Ebola Treatment Before Year End 8/19/2014
Esperite N.V. Implements Innovative Growth And Expansion Strategy With Already Positive EBITDA 8/19/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014
Akron Biotechnology, LLC Named 2014 Florida Companies To Watch Winner 8/19/2014
Fujifilm Diosynth Biotechnologies Expands Cell Culture Manufacturing Capacity With Addition Of Two New 2,000L Single-Use Bioreactors 8/19/2014
SIRION Biotech Release: Tissue Specific Optimized AAV Plasmids Are Now Available To Make Research & Therapy More Targeted 8/19/2014
Teen’s Organs Rejected Because He’s Gay 8/18/2014
St. Louis Radiology Group Chooses McKesson Corporation 8/18/2014
PDL BioPharma, Inc. (PDLI) Announces Plans To Issue Second Quarter Financial Results After Market Today And Reschedules Earnings Call For Tuesday, August 19 At 4:30pm EDT 8/18/2014
American Academy of Ophthalmology Joins FDA, Other Eye Health Organizations To Combat Risk Of Eye Infections In Contact Lens Wearers 8/18/2014
EastGate Acquisitions Corporation Augments Its Sub-Micron Self-Nanoemulsifying Platform Technology 8/18/2014
TNI BioTech Provides 2nd Notice of Annual Meeting September 4, 2014 8/18/2014
Joule Achieves Industry First With A 100% Increase In Photosynthetic Efficiency 8/18/2014
INFORMEX® Introduces Tiered Badge Pricing, CPhI Partnership Among Key Enhancements For 2015 8/18/2014
Tianyin Pharmaceutical Co, Inc. Release: Qionglai Facility (QLF) Schedules September For GMP Examination 8/18/2014
Cellular Biomedicine Group (CBMG)'s Stock Price Quadruples In Two Months 8/18/2014
Acura Pharmaceuticals, Inc. (ACUR) Provides Update On FDA Discussions Surrounding Development Of Aversion Hydrocodone With Acetaminophen Tablet 8/18/2014
Society For Clinical Research Sites Announces Additional Commitment From INC Research, Inc. For Global Site Engagement Initiatives 8/18/2014
Cellular Biomedicine Group (CBMG) To Ring The NASDAQ Stock Market Closing Bell 8/18/2014
CytoDyn Announces Webcast For Annual Shareholder Meeting 8/18/2014
Endocyte, Inc. (ECYT) Scientific Team Selected To Receive 2015 George And Christine Sosnovsky Award For Cancer Research 8/15/2014
Agile Therapeutics, Inc. Reports Second Quarter 2014 Financial Results 8/15/2014
Lentigen Corporation Announces Sale Of Lentiviral Vector Manufacturing Business And Change Of Name To Opus Bio, Inc. 8/15/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Eurofins Genomics Adds Next Generation Sequencing To ISO17025 Accredited Testing Portfolio 8/14/2014
Novozymes, Inc. (NZYMb.CO) Increases 2014 Profit Outlook 8/14/2014
Procter & Gamble (PG) Release: Prilosec OTC Makes Final Stop Of Zero Burn* Summer Tour At Chicago Air And Water Show 8/14/2014
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014
Sigma-Aldrich Corporation (SIAL) Release: Cerilliant Introduces New Certified Spiking Solutions® Of 2C Amine Internal Standards 8/14/2014
Leidos Awarded Contract By General Services Administration 8/14/2014
CBLPath Announces Expansion Of Cytopathology Department 8/14/2014
Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy For Urinary Incontinence 8/14/2014
Google Inc.’s Mysterious Anti-Aging Company Calico Now Has A Web Presence 8/13/2014
Popular Toothpaste Contains Cancer-Causing Ingredient 8/13/2014
How To Look 10 Years Younger: Google Inc. Attacks Wrinkles 8/13/2014
PHT Corporation VP Of Clinical Science And Consulting Services Dr. Susan Dallabrida Named To The Pharmavoice 100 8/13/2014
Mologen AG (MOLGF.PK): Preparation And Launch Of New Studies Characterized The First Half-Year 2014 8/13/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 8/13/2014
NanoViricides, Inc. (NNVC.PK) To Ring Opening Bell At New York Stock Exchange 8/13/2014
Royal DSM Expands Its Biomedical Business With The Launch Of Its Cellular Therapy Development Services 8/13/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
FV Pharma International Corp. Announces That The Name And Symbol Change Process Are Now Completed 8/13/2014
Handpicked By Ex-CEO, Takeda Pharmaceutical Co. Ltd. (TKPYY)'s New Leader Vows To Remain Japanese-Based, Will Attempt To Get Company Out Of Slump 8/12/2014
5 Things Celgene Corporation (CELG)'s Management Wants You To Know 8/12/2014
Lithera Announces Company Name Change To Neothetics, Inc. 8/12/2014
Huron Consulting Group Launches Clinical Trial Data Analytics and Visualization Service 8/12/2014
Abcam plc (ABC.L) Establishes New Direct Service For Australia And New Zealand 8/12/2014
Ligand Pharmaceuticals Inc. (LGND) Announces Proposed Offering Of $225 Million Of Convertible Senior Notes And Announces $200 Million Share Repurchase Program 8/12/2014
Insmed Incorporated (INSM) Announces Proposed Public Offering Of Common Stock 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Aegate Launches Aegate Safe Medicine Ecosystem Partner Program 8/12/2014
Cannabis Science Inc. Increases Equity Position To 50.1% In Michigan Green Technologies LLC, Positioning Company As Leader In Evolving Michigan Medical Cannabis And Hemp Industries 8/12/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars 8/12/2014
m2p-labs Expands To Eastern Europe 8/12/2014
Cedars-Sinai Heart Institute Opens First-Of-Its-Kind Research Stem Cell Clinic For Cardiac Patients 8/12/2014
ZAI Lab Of Shanghai In-Licenses Two Respiratory Drugs From Sanofi 8/12/2014
BTG plc (BTG.L) Release: First Varicose Vein Patient Treated With FDA-Approved Varithena® (polidocanol Injectable Foam) 1% 8/11/2014
Baxter International, Inc. (BAX) Opens Its First State-Of-The-Art Biologics Facility In Asia 8/11/2014
Top 10 Pharma Firms Of 2014 (So Far) 8/11/2014
Endo Boss Confident That New U.S. Rules Will Not Force Drugmaker Back Into America's Tax Regime 8/11/2014
Stampede Of Takeovers Could Mean Growth Ahead, Or Not 8/11/2014
Standing On A Ledge Once Again, Amicus Therapeutics, Inc. (FOLD) Holds Breath For Latest Study 8/11/2014
Medical University of South Carolina Hollings Cancer Center Unveils New Cancer-Fighting Technology 8/11/2014
Advaxis, Inc.'s Scientific Founder, Dr. Yvonne Paterson, Named One Of The Pharmavoice 100 Most Inspiring People In Life Sciences 8/11/2014
TONIX Pharmaceuticals, Inc. Announces Transfer To The NASDAQ Global Market 8/11/2014
Certara Corporation’s New Muse Invent Allows Chemistry Researchers To Design Drug Candidates That Are Synthetically Feasible 8/11/2014
OXIS International, Inc. (OXIS) Announces Plans To Enter The Cannabis Biotech Sector, Completion Of Financing, Changes To The Board Of Directors 8/11/2014
Morphogenesis, Inc. Chooses Florida Veterinary Referral Center As Newest Licensee For Its Immunefx™ Cancer Vaccine 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
Intrexon Corporation Launches Leadership Platform In Bovine Genetics 8/11/2014
Catylix And Aspira Scientific Announce Launch Of The "New Substituent Of The Future" 8/11/2014
Chiltern International Ltd. Joins CDISC As Gold Member 8/11/2014
Extending Patent Protections To Discover The Next Life-Saving Drugs 8/11/2014
Gilead Sciences, Inc. (GILD) Will Charge $900 For Sovaldi In India 8/8/2014
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of Second Quarter 2014 Financials 8/8/2014
Mirati Therapeutics  (MRTX) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/8/2014
Biolog Inc. GEN III Technology Proves Its Accuracy In The First Direct Comparison Against Molecular Methods 8/8/2014
Transposagen Biopharmaceuticals, Inc.'s Footprint-Free™ Gene Editing System Corrects Beta-Thalassemia Disease Mutation In Human IPS Cells 8/8/2014
Pivotal Therapeutics Inc. To Explore Potential Commercial Partnership Opportunities In China 8/7/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
QLT Inc. (QLTI) Announces Adoption Of Advance Notice Policy 8/7/2014
Ashland Inc.  (ASH) Commits To Major Capacity Expansion For Klucel™ Products 8/7/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results 8/7/2014
KaloBios Pharmaceuticals, Inc. (KBIO) Provides Clinical Update And Reports Second Quarter Financial Results 8/7/2014
HemoGenix Inc. Announces A Major Advancement To Promote Best Practices In Umbilical Cord Blood Testing And Patient Transplant Outcomes 8/7/2014
Inergetics, Inc. Announces Additional Distribution At Winn-Dixie Stores 8/7/2014
RXi Pharmaceuticals (RXII) To Ring The NASDAQ Stock Market Closing Bell 8/7/2014
Cannabis Science Inc. In Final Negotiations To Establish Its First Medical Cannabis Facilities In Canada 8/7/2014
Advanced Cell Technology To Host Conference Call To Provide A Corporate Update 8/7/2014
Easton Pharmaceuticals (OP: EAPH) Announces The Completion And Shipping Of The mPact -GROzone Antimicrobial System; Provides Other Updates 8/7/2014
Best Of American Society of Clinical Oncology Selects Two Studies Co-Authored By US Oncology Research Affiliated Physicians 8/7/2014
Kathy Giusti Of The Multiple Myeloma Research Foundation (MMRF) Named To Pharmavoice 100 8/7/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
Biopredic International And Triangle Research Labs Announce The Distribution Of No-Spin Cryopreserved Heparg™ Cells By TRL In The United States 8/6/2014
Five Scientists From Bay Area's Sangamo BioSciences, Inc. (SGMO) Ranked Among The "World's Most Influential Scientific Minds" 8/6/2014
PuraMed BioScience Develops A Cannabis-Based Epilepsy Medication 8/6/2014
Children's Hospital of Philadelphia To Develop A Non-Profit Human Milk Bank To Serve Hospitalized Infants 8/6/2014
Integrated DNA Technologies Shares Comprehensive qPCR Resources 8/6/2014
Relmada Therapeutics Completes Name Change And Announces New Ticker 8/6/2014
Merck & Co., Inc. (MRK) Publishes 2013 Global Corporate Responsibility Report 8/6/2014
European Commission (EC) Publishes Approval Of Octapharma AG’s Human Cell Line Recombinant FVIII (Nuwiq®) Across All Age Groups In Haemophilia A 8/6/2014
Biotechnology Industry Organization (BIO) Launches Survey On FDA/Sponsor Interactions During Drug Development 8/6/2014
Axxess Pharma, Inc. Announces TapouT Product Line Now Approved By Australian Regulatory Authority: TGA 8/6/2014
IMS Health Introduces Cloud-Based Life Sciences Solution To Strengthen Customer Engagement, Local Sales Productivity 8/6/2014
Columbia Laboratories, Inc. (CBRX) Announces Sale Of IP And Technology For Legatrin P.M. To Lil' Drug Store Products 8/6/2014
Paradigm Initiates Genomic Profiling For Pharmatech, Inc.'s AccessPPM Cancer Registry Program 8/5/2014
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014
Renowned Fund Manager Says GlaxoSmithKline (GSK)'s Predicaments Are Only Temporary 8/5/2014
SeraCare Life Sciences, Inc. (SRLS) Expands Women's Health Portfolio With New ACCURUN® Controls 8/5/2014
Genomatica, Inc. Confirms Nylon Intermediates As Third Set Of Biobased Processes Under Development 8/5/2014
Mettler-Toledo (MTD) Presents Live Webinar On Better Moisture Determination 8/5/2014
Cadence Inc. Acquires New Capabilities, Expands Internationally 8/5/2014
PSI CRO Continues Growth in North America 8/5/2014
Regen BioPharma Provides Update On dCellVax Breast Cancer Immunotherapy 8/5/2014
Flamel Technologies (FLML) Notified Of FDA Communication To Unapproved Manufacturers Of Neostigmine Methylsulfate 8/5/2014
Struggling Takeda Pharmaceutical Co. Ltd. (TKPYY) To Raise The Bar On Research Projects, May Exit Certain Fields Of Therapy 8/5/2014
Allied Minds, Pharma Giant Bristol-Myers Squibb Company (BMY) Form New Company To Fuel Academic Research 8/4/2014
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014
Genzyme Corporation (GENZ) Receives Label Expansion For Lumizyme® (Alglucosidase Alfa) In The United States For The Treatment Of Pompe Disease 8/4/2014
BioAdaptives Announces First Product To Market 8/4/2014
Actinium Pharmaceuticals, Inc. (ATNM.OB) Provides Mid-Year Update Directed At Existing And Future Shareholders 8/4/2014
Accovion Announces New International Structure For Clinical Operations 8/4/2014
Omega Laboratories Quadruples Hair Drug Testing Capabilities 8/4/2014
Creative BioMart Has Newly Released Biosimilar Comparability Studies Service 8/4/2014
Pilgrim Quality Solutions Cited In Gartner 2014 Hype Cycle Reports 8/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Provides Pipeline Update 8/1/2014
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014
InVivo Therapeutics Corporation (NVIV) Announces Posting Of Management Presentation Recording From Annual Shareholders Meeting 8/1/2014
National Institutes of Health (NIH) Release: Genotype-Tissue Expression Project Expands Functional Studies Of Genomic Variation 8/1/2014
ICON: Pfizer Inc. (PFE) And Roche (RHHBY) Join ADDPLAN DF Consortium 8/1/2014
American Association for Clinical Chemistry Debuts Refreshed Brand Identity 8/1/2014
Afaxys Pharmaceuticals Products Now Available Nationwide; OCs Placed On Pennsylvania Medicaid's Preferred Oral Contraceptives List 8/1/2014
Onxeo Release: Key Milestones And Consolidated Accounts First Six Months 2014 8/1/2014
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner 8/1/2014
GlaxoSmithKline (GSK) May Separate Businesses 7/31/2014
50 Jobs Promised As Stem Cell Company Precious Cells BioBank Gets Bigger 7/31/2014
Weill Cornell Medical College Selects OpenTempo Workforce Optimization Solution 7/31/2014
Unilife Corporation (UNIS) Accelerates Investment To Meet Increasing Demand From New And Existing Customers 7/31/2014
Walgreens Named Exclusive Specialty Pharmacy Provider For Sigma-Tau Pharmaceuticals’s, Prescription Drugs: Adagen®, Cystaran Adagen® and Matulane Adagen® 7/31/2014
CytoDyn Announces Investment Community Call To Discuss Interim Results From Its Treatment Substitution Study In Patients With HIV 7/31/2014
Cannabis Science Inc. Initiates Scientific Cultivation Programs To Test Multiple Strains Of Cannabis To Obtain Extract Formulations For Clinical Drug Development Targeting Multiple Critical Ailments Starting With Cancer And Neurological Disorders 7/31/2014
CCRM Uses ambr15 For Pluripotent Stem Cell Expansion And Differentiation Research 7/31/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Second Quarter 2014 Financial Results 7/31/2014
genae Opens Offices In London 7/31/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 7/31/2014
Incyte Corporation (INCY) Reports 2014 Second-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 7/31/2014
Matinas BioPharma Launches Digital Corporate Communication Channels 7/31/2014
ThromboGenics NV (TBGNF)' JETREA Nominated For 2014 Prix Galien USA 7/31/2014
Association of Clinical Research Organizations (ACRO) Strongly Endorses COMPETE Act 7/31/2014
A*STAR And University of Warwick Launch First Engineering Doctorate Programme In Singapore 7/31/2014
Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals 7/30/2014
BioSpace (DHX) Map Features Midwest Biotech Leaders 7/30/2014
Rumor: Sarepta Therapeutics (SRPT) Chairman Moves To Keep CEO Out Of FDA Meetings 7/30/2014
Hantian Labs Ltd. Introduces Trailblazing Anti-Aging And Vitality Product For Men, GHBurn 7/30/2014
RXi Pharmaceuticals (RXII) Expands Clinical Program With Initiation Of Third Phase 2a Study With RXI-109 For Treatment Of Hypertrophic Scars 7/30/2014
Gilead Sciences, Inc. (GILD) Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug 7/30/2014
Kraig Biocraft Laboratories, Inc. Implements Innovative Protocol For Advanced Fiber Quality Control 7/30/2014
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program 7/30/2014
Harlan Provides Expertise For Biologics And Biosimilars 7/30/2014
Software Updates Simplify Protein Analysis For Avacta’s Optim® Instruments 7/30/2014
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) (Publ) 7/30/2014
Radius (RDUS) To Ring The NASDAQ Stock Market Closing Bell 7/30/2014
ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters To Washington, DC 7/29/2014
Phosphagenics Limited (POH.AX) Provides Update on Opioid Patch Program 7/29/2014
EastGate Acquisitions Corporation Announces Expansion Of Its Pharmaceutical Developments Implementing Its Sub-Micron Platform Technology 7/29/2014
GlaxoSmithKline (GSK) Denies Plans to Spin Off Consumer Health-Care Division 7/29/2014
Foundation Medicine, Inc. (FMI) Releases Enhanced Version Of FoundationOne® 7/29/2014
Sunshine Biopharma, Inc. Launches Sunshine Biopharma Canada Inc., A Wholly Owned Canadian Subsidiary In Anticipation Of Signing Manufacturing And Commercialization Contracts In Canada 7/29/2014
CAS DataLoggers Introduces RFID Cold Chain Solutions 7/29/2014
Batu Biologics Strategy For FDA Approval Of Lung Cancer Immunotherapy Featured In San Diego Business Journal 7/28/2014
New England Research Institutes Double-Certified As Women's Business Enterprise 7/28/2014
PPD, Inc. (PPDI) Adds Customer-Focused Strategic Leader To Drive Client Success 7/28/2014
Capsalus Corporation Changes Name To Foru Holdings, Inc. And Announces 1-For-165 Reverse Split Of Common Stock 7/25/2014
Galectin Therapeutics To Host Webcast To Discuss Findings From Cohort 2 Of Phase 1 Clinical Trial Of GR-MD-02 In Fatty Liver Disease With Advanced Fibrosis 7/25/2014
Asterias Biotherapeutics Announces Live Investor Webcast 7/25/2014
DelMar Pharmaceuticals Announces Change Of Fiscal Year End And Provides Update On Glioblastoma Clinical Trial 7/25/2014
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Second Quarter 2014 Financial Results 7/25/2014
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014
Novogen Limited (NVGN) And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™ 7/25/2014
Galapagos NV (GLPG.BR) Creates New Warrant Plan 7/25/2014



//-->